MAI Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.91M	Buy	6,357 +874	+16%	+$669K	0.03%	411
2025 Q4	$4.23M	Buy	5,483 +4,455	+433%	+$3.03M	0.02%	434
2025 Q3	$578K	Buy	1,028 +21	+2%	+$11.9K	﹤0.01%	872
2025 Q2	$529K	Buy	1,007 +114	+13%	+$63.6K	﹤0.01%	831
2025 Q1	$566K	Sell	893 -2,318	-72%	-$1.59M	﹤0.01%	783
2024 Q4	$2.29M	Sell	3,211 -570	-15%	-$478K	0.02%	461
2024 Q3	$3.97M	Sell	3,781 -250	-6%	-$278K	0.04%	287
2024 Q2	$4.24M	Buy	4,031 +36	+0.9%	+$34.9K	0.04%	282
2024 Q1	$3.85M	Buy	3,995 +2,845	+247%	+$2.71M	0.04%	289
2023 Q4	$1.01M	Sell	1,150 -23	-2%	-$18.9K	0.01%	459
2023 Q3	$965K	Buy	1,173 +45	+4%	+$35.4K	0.01%	439
2023 Q2	$811K	Buy	1,128 +161	+17%	+$124K	0.01%	479
2023 Q1	$795K	Buy	967 +136	+16%	+$103K	0.01%	485
2022 Q4	$600K	Buy	831 +48	+6%	+$35.4K	0.01%	562
2022 Q3	$539K	Buy	783 +179	+30%	+$113K	0.01%	530
2022 Q2	$357K	Buy	604 +294	+95%	+$191K	0.01%	645
2022 Q1	$217K	Sell	310 -54	-15%	-$34.2K	﹤0.01%	806
2021 Q4	$230K	Buy	+364	New	+$224K	﹤0.01%	785